Dr. Kathryn E. Welch is a rheumatologist in Overland Park,Kansas. She graduated from University of Kansas School of Medicine in 1985 and has been in practice for 37 years.
Female
1891789343
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | 95.0 | 86.0 | 16.0 |
| Blood test, comprehensive group of blood chemicals | 121.0 | 110.0 | 92.0 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test | 123.0 | 110.0 | 39.0 |
| Red blood cell sedimentation rate, to detect inflammation | 115.0 | 106.0 | 22.0 |
| Measurement C-reactive protein for detection of infection or inflammation | 115.0 | 106.0 | 50.0 |
| Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 16.0 | 14.0 | 271.0 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 76.0 | 42.0 | 64.0 |
| Infusion of chemotherapy into a vein up to 1 hour | 14.0 | 11.0 | 321.0 |
| Infusion of chemotherapy into a vein | 14.0 | 11.0 | 129.0 |
| Established patient office or other outpatient visit, typically 15 minutes | 25.0 | 25.0 | 103.0 |
| Established patient office or other outpatient, visit typically 25 minutes | 66.0 | 64.0 | 163.0 |
| Established patient office or other outpatient, visit typically 40 minutes | 24.0 | 24.0 | 225.0 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10800.0 | 22.0 | 13.0 |
| Injection, infliximab, excludes biosimilar, 10 mg | 690.0 | 11.0 | 147.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.